These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19075583)

  • 1. Disease state, age, sex, and post-mortem time-dependent expression of proteins in AD vs. control frontal cortex brain samples.
    Müller T; Jung K; Ullrich A; Schrötter A; Meyer HE; Stephan C; Egensperger R; Marcus K
    Curr Alzheimer Res; 2008 Dec; 5(6):562-71. PubMed ID: 19075583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Yoo BC; Fountoulakis M; Cairns N; Lubec G
    Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
    Sathe G; Albert M; Darrow J; Saito A; Troncoso J; Pandey A; Moghekar A
    J Neurochem; 2021 Mar; 156(6):988-1002. PubMed ID: 32614981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes.
    Müller T; Loosse C; Schrötter A; Schnabel A; Helling S; Egensperger R; Marcus K
    Curr Alzheimer Res; 2011 Aug; 8(5):573-82. PubMed ID: 21453247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE.
    Crecelius A; Götz A; Arzberger T; Fröhlich T; Arnold GJ; Ferrer I; Kretzschmar HA
    Proteomics; 2008 Mar; 8(6):1276-91. PubMed ID: 18283663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome.
    Franzén B; Yang Y; Sunnemark D; Wickman M; Ottervald J; Oppermann M; Sandberg K
    Proteomics; 2003 Oct; 3(10):1920-9. PubMed ID: 14625854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R; Cairns N; Fountoulakis M; Lubec G
    Neurobiol Aging; 2001; 22(4):547-53. PubMed ID: 11445254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
    Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
    Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals.
    Edgar PF; Schonberger SJ; Dean B; Faull RL; Kydd R; Cooper GJ
    Mol Psychiatry; 1999 Mar; 4(2):173-8. PubMed ID: 10208449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance.
    Preece P; Cairns NJ
    Brain Res Mol Brain Res; 2003 Oct; 118(1-2):60-71. PubMed ID: 14559355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural HO-1/sterol interactions in vivo: implications for Alzheimer's disease.
    Hascalovici JR; Song W; Liberman A; Vaya J; Khatib S; Holcroft C; Laferla F; Schipper HM
    Neuroscience; 2014 Nov; 280():40-9. PubMed ID: 25218961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific DNA methylation differences in Alzheimer's disease pathology.
    Zhang L; Young JI; Gomez L; Silva TC; Schmidt MA; Cai J; Chen X; Martin ER; Wang L
    Acta Neuropathol Commun; 2021 Apr; 9(1):77. PubMed ID: 33902726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
    Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
    J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
    Sizova D; Charbaut E; Delalande F; Poirier F; High AA; Parker F; Van Dorsselaer A; Duchesne M; Diu-Hercend A
    Neurobiol Aging; 2007 Mar; 28(3):357-70. PubMed ID: 16519965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synaptic proteome in Alzheimer's disease.
    Chang RY; Nouwens AS; Dodd PR; Etheridge N
    Alzheimers Dement; 2013 Sep; 9(5):499-511. PubMed ID: 23154051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
    Castaño EM; Roher AE; Esh CL; Kokjohn TA; Beach T
    Neurol Res; 2006 Mar; 28(2):155-63. PubMed ID: 16551433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hypoxia-related proteins in medaka (Oryzias latipes) brain tissue by difference gel electrophoresis and de novo sequencing of 4-sulfophenyl isothiocyanate-derivatized peptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Oehlers LP; Perez AN; Walter RB
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):120-33. PubMed ID: 16905368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight species of tau in Alzheimer's disease are dependent on tau phosphorylation sites but not on delayed post-mortem delay in tissue processing.
    Santpere G; Puig B; Ferrer I
    Neurosci Lett; 2006 May; 399(1-2):106-10. PubMed ID: 16488541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.